Skip to content
Disclosery

Endurant Capital Management LP

Follow

13F filer, CIK 1633055, San Mateo, CA

Endurant Capital Management LP reported $114,544,687 across 34 holdings for the quarter ended 2023-06-30, in a 13F-HR filed 2023-08-14. Its ten largest share positions make up 64.82% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001633055-23-000007

Period
2023-06-30
Reported value
$115M
Holdings
34
Top 10 weight
64.82%
New
15
Sold out
31

Largest buys vs the previous quarter

SecurityShares changeApprox. value
Anew+45,762$5.5M
IQVnew+19,169$4.31M
BSXnew+60,991$3.3M
CAHnew+31,696$3M
MDTnew+27,181$2.39M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BMRNreduced-212,014-$18.4M
BDXreduced-63,490-$16.8M
ELVreduced-31,690-$14.1M
SBRAexited-1,165,923-$13.4M
TEVAexited-762,264-$6.75M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2023

Share positions as resolved from 13F-HR 0001633055-23-000007, largest first. % of portfolio is the value over $77,586,085, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LABORATORY CRP OF AMER HLDGSLABORATORY CRP OF AMER HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 34,718 shares; 2022Q3: 97,245 shares; 2022Q4: 90,924 shares; 2023Q1: 45,240 shares; 2023Q2: 32,569 shares 32,569$7.86M10.13%-12,671
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 40,372 shares; 2022Q3: 34,099 shares; 2022Q4: 49,678 shares; 2023Q1: 27,799 shares; 2023Q2: 25,816 shares 25,816$7.24M9.34%-1,983Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 126,003 shares; 2023Q1: 49,573 shares; 2023Q2: 49,332 shares 49,332$5.69M7.34%-241Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 45,762 shares 45,762$5.5M7.09%newTimeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 47,442 shares; 2022Q3: 70,535 shares; 2022Q4: 40,452 shares; 2023Q1: 59,903 shares; 2023Q2: 58,036 shares 58,036$4.72M6.09%-1,867Timeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 101,048 shares; 2022Q4: 141,420 shares; 2023Q1: 97,257 shares; 2023Q2: 60,808 shares 60,808$4.35M5.61%-36,449Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 19,169 shares 19,169$4.31M5.55%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 25,975 shares; 2022Q3: 145,374 shares; 2022Q4: 84,357 shares; 2023Q1: 255,616 shares; 2023Q2: 43,602 shares 43,602$3.78M4.87%-212,014Timeline
BDXBECTON DICKINSON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 34,282 shares; 2022Q4: 6,761 shares; 2023Q1: 76,850 shares; 2023Q2: 13,360 shares 13,360$3.53M4.55%-63,490Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 418,165 shares; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 60,991 shares 60,991$3.3M4.25%newTimeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 31,696 shares 31,696$3M3.86%newTimeline
QIAGEN NVQIAGEN NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 398,221 shares; 2022Q3: 303,928 shares; 2022Q4: 40,749 shares; 2023Q1: 178,894 shares; 2023Q2: 62,708 shares 62,708$2.82M3.64%-116,186
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 16,402 shares; 2022Q4: 26,077 shares; 2023Q1: 37,326 shares; 2023Q2: 5,636 shares 5,636$2.5M3.23%-31,690Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 27,181 shares 27,181$2.39M3.09%newTimeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 82,929 shares; 2022Q4: 78,144 shares; 2023Q1: 26,471 shares; 2023Q2: 32,710 shares 32,710$2.21M2.85%+6,239Timeline
VTRVENTAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 85,683 shares; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 41,575 shares 41,575$1.97M2.53%newTimeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 760,228 shares; 2022Q3: 1,064,295 shares; 2022Q4: 1,063,953 shares; 2023Q1: 512,744 shares; 2023Q2: 368,438 shares 368,438$1.9M2.45%-144,306Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 142,071 shares; 2022Q3: 107,713 shares; 2022Q4: 243,122 shares; 2023Q1: 230,006 shares; 2023Q2: 79,471 shares 79,471$1.68M2.16%-150,535Timeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 41,100 shares; 2022Q3: 44,286 shares; 2022Q4: 16,728 shares; 2023Q1: 8,414 shares; 2023Q2: 7,643 shares 7,643$1.32M1.7%-771Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 15,246 shares 15,246$1.13M1.45%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: 6,137 shares; 2023Q2: 2,565 shares 2,565$1000K1.29%-3,572Timeline
BLUEBIRD BIO INCBLUEBIRD BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: 525,059 shares; 2023Q2: 281,441 shares 281,441$926K1.19%-243,618
SELECTA BIOSCIENCES INCSELECTA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 4,611,635 shares; 2022Q3: 3,938,409 shares; 2022Q4: 3,777,618 shares; 2023Q1: 2,166,328 shares; 2023Q2: 686,143 shares 686,143$768K0.99%-1,480,185
ADAPYADAPTIMMUNE THERAPEUTICS PLC SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 1,824,065 shares; 2022Q3: 1,788,517 shares; 2022Q4: 1,733,236 shares; 2023Q1: 1,660,835 shares; 2023Q2: 821,038 shares 821,038$759K0.98%-839,797Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 16,189 shares; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 9,153 shares 9,153$729K0.94%newTimeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 36,784 shares; 2023Q1: 19,585 shares; 2023Q2: 29,282 shares 29,282$555K0.72%+9,697
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 10,741 shares 10,741$471K0.61%newTimeline
MASIMASIMO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 2,850 shares 2,850$469K0.6%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 40,184 shares 40,184$363K0.47%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 433,035 shares; 2023Q1: 57,043 shares; 2023Q2: 20,754 shares 20,754$336K0.43%-36,289Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput6,100$27.1Mnew
BMRNBIOMARIN PHARMACEUTICAL INC COMcall93,600$8.11Mnew
TEVATEVA PHARMACEUTICAL INDS LTD ADRcall175,000$1.32Mnew
BIOXCEL THERAPEUTICS INCBIOXCEL THERAPEUTICS INC COMcall57,100$380Knew

Sold out in Q2 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SBRASABRA HEALTH CARE REIT INC1,165,923$13.4Mshares
TEVATEVA PHARMACEUTICAL INDS LTD762,264$6.75Mshares
ICLRICON PUB LTD CO26,830$5.73Mshares
MRNAMODERNA INC36,130$5.55Mshares
AVTRAVANTOR INC225,615$4.77Mshares
BIOBIO RAD LABS INC9,185$4.4Mshares
PFEPFIZER INC73,265$2.99Mshares
MCKMCKESSON CORP7,312$2.6Mshares
PTCTPTC THERAPEUTICS INC53,247$2.58Mshares
DXCMDEXCOM INC22,185$2.58Mshares
DOCHEALTHPEAK PROPERTIES INC100,685$2.21Mshares
XRAYDENTSPLY SIRONA INC55,992$2.2Mshares
TMOTHERMO FISHER SCIENTIFIC INC3,744$2.16Mshares
CNCCENTENE CORP DEL29,586$1.87Mshares
IVERIC BIO INCIVERIC BIO INC64,704$1.57Mshares
GRITSTONE BIO INCGRITSTONE BIO INC540,657$1.5Mshares
CORCENCORA INC9,153$1.47Mshares
QUREUNIQURE NV71,040$1.43Mshares
BAXBAXTER INTL INC34,508$1.4Mshares
RMDRESMED INC6,345$1.39Mshares
ZBHZIMMER BIOMET HOLDINGS INC9,283$1.2Mshares
ACRSACLARIS THERAPEUTICS INC83,891$679Kshares
CATALENT INC USD 0.01CATALENT INC USD 0.019,144$601Kshares
IOVAIOVANCE BIOTHERAPEUTICS INC80,455$492Kshares
CHRSCOHERUS ONCOLOGY INC64,956$444Kshares
MRVIMARAVAI LIFESCIENCES HLDGS I20,753$291Kshares
BIOXCEL THERAPEUTICS INCBIOXCEL THERAPEUTICS INC11,640$217Kshares
BIODESIX INCBIODESIX INC113,267$211Kshares
ADDEX THERAPEUTICS LTDADDEX THERAPEUTICS LTD120,748$114Kshares
ATHENEX INCATHENEX INC42,651$56.7Kshares
VKTXVIKING THERAPEUTICS INC442$7.36Kcall

How Q2 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001633055-23-000007 base2023-08-14acceptance time not in the bulk data set